Therapeutic Effects of Ischemic-Preconditioned Exosomes in Cardiovascular Diseases

Adv Exp Med Biol. 2017:998:271-281. doi: 10.1007/978-981-10-4397-0_18.

Abstract

Despite years of researches, cardiovascular disease (CVD) remains the most common cause of death around the world. Lots of studies showed that by pretreating with short nonfatal ischemia in in situ organ or distant organ, one could develop tolerance to the following fatal ischemia. The process is called ischemic preconditioning (IPC). IPC prepare the heart for damage by producing inflammatory signals, miRNA, neuro system stimulation and exosomes. Among them, exosomes have been gaining increasing interest since it is characterized by its capability to carry information and its specific ligand-receptor system. Here we will discuss IPC induced exosomes and its protective effects during ischemic heart disease.

Keywords: Cardiovascular diseases; Exosomes; Ischemic preconditioning.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Hypoxia
  • Exosomes / metabolism
  • Exosomes / pathology
  • Exosomes / transplantation*
  • Humans
  • Ischemic Preconditioning, Myocardial / methods*
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / pathology
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / surgery*
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / pathology
  • Myocardial Reperfusion Injury / physiopathology
  • Myocardial Reperfusion Injury / prevention & control*
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Oxygen / metabolism*
  • Proteasome Endopeptidase Complex / metabolism
  • Recovery of Function
  • Regeneration
  • Stem Cell Transplantation*

Substances

  • Proteasome Endopeptidase Complex
  • Oxygen